An introduction to PrEP and LGBT centered care
The following resources are designed to provide an introduction to PrEP (pre-exposure prophylaxis), and the drugs involved, how PrEP works and evidence of its efficacy, as well as an introduction to providing LGBT Centered Care.
This presentation provides an overview of pre-exposure prophylaxis, or PrEP, including what drugs are involved, the science behind how PrEP works, and evidence of its efficacy. The video also introduces the Canadian guideline on HIV pre-exposure prophylaxis and non-occupational postexposure prophylaxis, a resource published in CMAJ in December 2017 healthcare providers to offer PrEP in their practice.
This video was created before tenofovir alafenamide and emtricitabine (TAF/FTC) also know as Descovy was approved in Canada for PrEP. See video below for more information on Descovy.
This presentation provides an introduction to providing healthcare services to lesbian, gay, bisexual and transgender patients. What are the specific needs of LGBT patients? How can you create a safe environment for engaging LGBT patients about the sexuality and other health needs?
This website provides general information about Pre-Exposure Prophylaxis for HIV. This site is not intended to be a substitute for professional medical advice, diagnosis, or treatment. We strongly urge individuals considering starting PrEP to consult with a qualified medical practitioner prior to undertaking any decision, use or action of a medical nature.